Human Thrombomodulin ELISA Kit (CD141) (ab46508)
Key features and details
- Sensitivity: 0.31 ng/ml
- Range: 0.625 ng/ml - 20 ng/ml
- Sample type: Cell culture supernatant, Plasma, Serum
- Detection method: Colorimetric
- Assay type: Sandwich (quantitative)
- Reacts with: Human
製品の概要
-
製品名
Human Thrombomodulin ELISA Kit (CD141)
Thrombomodulin キット 製品一覧 -
検出方法
Colorimetric -
再現性
Intra-Assay(同時再現性) サンプル N 平均値 SD CV% Serum 6 3.9% Inter-Assay(日差再現性) サンプル N 平均値 SD CV% Serum 6 9.8% -
サンプルの種類
Cell culture supernatant, Serum, Plasma -
アッセイタイプ
Sandwich (quantitative) -
検出感度
< 0.31 ng/ml -
検出範囲
0.625 ng/ml - 20 ng/ml -
添加回収試験
109 %
-
全工程の試験時間
1h 45m -
ステップ
Multiple steps standard assay -
種交差性
交差種: Human -
製品の概要
Abcam’s Thrombomodulin (CD141) Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the quantitative measurement of Thrombomodulin (CD141) in serum, plasma, buffered solutions and supernatants.
A monoclonal antibody specific for Thrombomodulin has been coated onto the wells of the microtiter strips provided. Samples, including standards of known Thrombomodulin concentrations, control specimens or unknowns are pipetted into these wells. During the first incubation, the standards or samples and a biotinylated monoclonal antibody specific for Thrombomodulin are simultaneously incubated. After washing, the enzyme Streptavidin-HRP, that binds the biotinylated antibody is added, incubated and washed. A TMB substrate solution is added which acts on the bound enzyme to induce a colored reaction product. The intensity of this colored product is directly proportional to the concentration of Thrombomodulin present in the samples.
This kit will recognize both endogenous and recombinant Human Thrombomodulin.
-
アプリケーション
適用あり: Sandwich ELISAmore details -
試験プラットフォーム
Microplate
製品の特性
-
保存方法
Store at +4°C. Please refer to protocols. -
内容 ラベル 1 x 96 tests 2 x 96 tests 1 x 96 tests 2 x 96 tests 10X Standard Diluent Buffer Black 1 x 15ml 1 x 25ml 1 x 15ml 1 x 25ml 200X Wash Buffer White 1 x 10ml 2 x 10ml 1 x 10ml 2 x 10ml Biotinylated Antibody Diluent Red 1 x 7ml 1 x 13ml 1 x 7ml 1 x 13ml Biotinylated anti-Thrombomodulin Red 1 x 400µl 2 x 400µl 1 x 400µl 2 x 400µl Chromogen TMB Substrate Solution 1 x 11ml 1 x 24ml 1 x 11ml 1 x 24ml Control Silver 2 vials 4 vials 2 vials 4 vials HRP Diluent Red 1 x 12ml 1 x 23ml 1 x 12ml 1 x 23ml Stop Reagent Black 1 x 11ml 2 x 11ml 1 x 11ml 2 x 11ml Streptavidin-HRP 2 x 5µl 4 x 5µl 2 x 5µl 4 x 5µl Thrombomodulin Microplate (12 x 8 well strips) 1 unit 2 units 1 unit 2 units Thrombomodulin Standard (lyophilized) Yellow 2 vials 4 vials 2 vials 4 vials -
研究分野
-
機能
Thrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This complex is responsible for the conversion of protein C to the activated protein C (protein Ca). Once evolved, protein Ca scissions the activated cofactors of the coagulation mechanism, factor Va and factor VIIIa, and thereby reduces the amount of thrombin generated. -
組織特異性
Endothelial cells are unique in synthesizing thrombomodulin. -
関連疾患
Defects in THBD are the cause of thrombophilia due to thrombomodulin defect (THR-THBD) [MIM:188040]. A hemostatic disorder characterized by a tendency to thrombosis.
Defects in THBD are a cause of susceptibility to hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926]. An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. Note=Susceptibility to the development of atypical hemolytic uremic syndrome can be conferred by mutations in various components of or regulatory factors in the complement cascade system. Other genes may play a role in modifying the phenotype. -
配列類似性
Contains 1 C-type lectin domain.
Contains 6 EGF-like domains. -
翻訳後修飾
N-glycosylated.
The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains. -
細胞内局在
Membrane. - Information by UniProt
-
別名
- AHUS 6
- AHUS6
- BDCA 3
see all -
参照データベース
- Entrez Gene: 7056 Human
- Omim: 188040 Human
- SwissProt: P07204 Human
- Unigene: 2030 Human
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab46508の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
Sandwich ELISA |
Use at an assay dependent concentration.
|
特記事項 |
---|
Sandwich ELISA
Use at an assay dependent concentration. |
画像
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (18)
ab46508 は 18 報の論文で使用されています。
- Bauer C et al. Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation. Kidney Int Rep 7:797-809 (2022). PubMed: 35497798
- Pomponio G et al. Tocilizumab in COVID-19 interstitial pneumonia. J Intern Med 289:738-746 (2021). PubMed: 33511686
- Ma L et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. bioRxiv N/A:N/A (2021). PubMed: 33655244
- Marchetti M et al. Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction. TH Open 5:e253-e263 (2021). PubMed: 34235394
- Mehic D et al. Thrombomodulin in patients with mild to moderate bleeding tendency. Haemophilia 27:1028-1036 (2021). PubMed: 34628704